Peer-influenced content. Sources you trust. No registration required. This is HCN.

Articles related to MYELOMA

Hematology Advisor

Palliative Radiotherapy Linked to Pain Response in Multiple Myeloma

Hematology November 6th 2023

Clinical Oncology News

APHEXDA in Combination with Filgrastim Approved For Patients with Multiple Myeloma

Hematology/Oncology October 2nd 2023

Oncology News Central (ONC)

BMS Accused by HMO of Patent Fraud to Allegedly Sustain Pomalyst Monopoly

Hematology/Oncology September 11th 2023

Myeloma Research News

Elranatamab, Now Elrexfio, Approved for Hard-to-treat Myeloma

Hematology/Oncology September 5th 2023

Oncology News Central (ONC)

FDA Grants Accelerated Approval to Elranatamab for Relapsed or Refractory Multiple Myeloma

Hematology/Oncology August 21st 2023

Roswell Park

Roswell Park Study is First to Show That Exercise Strengthens Immune System in Multiple Myeloma Patients

Hematology/Oncology August 14th 2023

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form